Pioglitazone (PIO), a synthetic ligand for peroxisome proliferator activated receptor γ (PPARγ), is clinically used to treat type 2 diabetes mellitus. However, little is known on its endothelial protective effects and the underlying mechanisms. In this study, we sought to investigate PIO's endothelial protective effects and its likely mechanisms.
Introduction
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia. Chronic hyperglycemia results in target organ impairments by oxidative stress etc., including angiopathy, retinopathy, renopathy and neuropathy so on (Nathan 2014). Among these, macroangiopathy has been considered as a dominant factor of morbidity and mortality in DM (Ghosh et al. 2015) . Therefore, control of hyperglycemia and protection of vascular endothelial cells (VECs) are therapeutic strategies for diabetic angiopathy. Clinically, oral hypoglycemic agents, insulin, and insulin sensitizers etc. are the common used drugs for type 2 diabetes mellitus (T2DM) (Fox et al. 2015) .
Pioglitazone (PIO), one of thiazolidinediones (TZDs), serves as an insulin sensitizer and is often used for therapy of T2DM (Seong et al. 2015) . As for its action mechanism, it is commonly recognized that PIO ameliorates insulin sensitivity via a peroxisome proliferator activated receptor γ (PPARγ)-dependent insulin signaling trans-activation mechanism (Huang et al. 2012) . PPARγ, a ligand-dependent nuclear transcription factor, belongs to a super-family member of nuclear transcription factors which regulate gene expression in response to the specific ligands including endogenous and exogenous ligands (McCarthy et al. 2013) . Once PPARγ binds with PIO, the heterodimer of PPARγ-RXR (retinoid X receptors) dissociates first with co-repressors of PPARγ including NCoR, and Tab2 etc. and associate subsequently with its co-activators such as PGC1 etc. to form a complex of PPARγ-RXR-PGC1.
Ultimately, the complex combines to the PPAR responsive elements (PPRE) of target D r a f t genes and launches the transcription of target genes (Yu et al. 2015) . The aforementioned process is called as PPRE-dependent trans-activation mechanism. It is through PPRE-dependent trans-activation mechanism that PIO plays the crucial roles in the gluco-lipid metabolism and adipogenesis (Wang et al. 2015) .
Nuclear factor κB (NFκB), a predominant transcription factor, plays central roles in inducing the expressions of a wide variety of genes such as cytokines (TNFα, IL6, GM-CSF), chemokines (MIP1α, MCP1) and adhesion molecules (E-selectin, VCAM1, ICAM1). All these molecules are extensively involved in systemic inflammation (Kaplan et al. 2014) . Physiologically, NFκB exists in the cytoplasm in a heterotrimer of NFκB p65, p50 and inhibitory kappa B (IκBα). When cells are stimulated by injuries, hypoxia, and microorganisms etc., the IκB kinase (IKKα/β), an upstream protein of NFκB signaling, is activated. Activated IKKα/β phosphorylates IκBα at serine 32 and 36 and subsequently the degradation of IκBα occurs. The degradation of D r a f t is referred as 'off-target' effect (Marder et al. 2013) . Moreover, for the former, there are also two views. One is a NFκB-dependent mechanism while the other is an AP1-dependent mechanism (Monsalve et al. 2013) .
A variety of studies demonstrated that cross-talk of PPARγ-mediated insulin signaling and NFκB-mediated inflammation signaling fine tunes the onset and development of atherosclerosis induced by hyperglycemia (Marcone et al. 2015) . As critical endocrine cells and a crucial barrier between blood and vessel stroma, integrity and normal functionality of VECs are required for the maintenance of vascular homeostasis (Jufri et al. 2015) . Unfortunately, little is known on PIO's endothelial protective effects and its underlying mechanisms. Accordingly, in the present study, we proposed and sought to investigate the hypothesis that PIO protects endothelial cell against dysfunction induced by high glucose (HG) through a D r a f t (Cambridge, UK Inc., Shanghai, CHN). The cell culture was performed as described in our previous report (Huang et al. 2010) . Briefly, the cells were cultured in a 6-well plate or a 24-well plate and propagated in DMEM, which was supplemented with 10% FBS, 100 IU/ml penicillin, and 0.1 mg/ml streptomycin. The cells were cultured at 37ºC in a 95% O 2 -5% CO 2 humidified atmosphere. The HUVECs with 95% confluence were used for the following experiments.
Model establishment of HG-induced endothelial cell dysfunction
The model establishment of HG-induced endothelial cell dysfunction was performed as described in our previous report (Liu et al. 2014 hours, while the cells untreated with anything were considered as a control.
Eventually, the cell supernatants were collected to detect all biochemical parameters and the cells were used to measure the cell viability, the caspase3 activity, IKKα/β mRNA and its protein levels and cytoplasmic and nuclear NFκB p65 levels.
The protective effects of PIO on the cell dysfunction induced by HG were mediated by PPARγ
The 95% confluent WT-HUVECs were first exposed to HG for 48 hours, and then pretreated with 10 µM of GW9662 for 30 minutes, and finally treated with 20 µM of D r a f t in our previous report with a minor modification (Liu et al. 2014) . Briefly, the WT-HUVECs were seeded in a 96-well plate at a density of 2 × 10 4 cells per well and cultured in the DMEM. When grown to a 95% confluence, the cells were treated as described in the section 2.4.1. Subsequently, the cells were further incubated with 10 microliters of MTT (5 mg/ml) for 4 hours and treated with 100 microliters of DMSO for 15 minutes. Finally, optical density values (OD) at wavelength of 490 nm were measured.
Determination of caspase3 activity
The caspase3 activity was determined using a caspase3 activity assay kit which was based on the capability of caspase3 to cleave acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA) producing yellow formazan product p-nitroaniline (pNA). The procedure was performed following the manufacturer's instructions. Briefly, cells
were lysed with the lysis solution followed by incubation on ice for 15 minutes and centrifugation (16,000g) for 10 minutes at 4°C. The supernatants were collected and added with the reaction buffer and the coupling substrate followed by 37°C water bath for 1 hour. The absorbance values were determined by enzyme-linked assay at 405 nm wavelength. The values were regarded as the relative activity of caspase3.
Quantitative assays of the levels of ET1, TNFα and IL6 by ELISA
The quantitative assays of the levels of ET1, TNFα and IL6 were performed using the Quantikine ELISA Kits according to the manufacturer's instructions. Briefly, 50 microliters of cell supernatants were first added to a 96-well polystyrene microplate pre-coated with indicated monoclonal antibodies and incubated for 2 hours at room D r a f t temperature on the shaker. Next, after five times of gentle washes with PBS, 100 microliters of secondary antibodies conjugated to horseradish peroxidase were added and further incubated for 2 hours. Then, 100 microliters of substrate solutions were added and treated for 30 minutes at room temperature. Ultimately, 100 microliters of stop solutions were added and the OD values were read at 450 nm in a microplate reader (Bio-Rad Laboratories).
Measurement of nitrite levels
Nitrite levels in the supernatants are commonly considered as an indicator of NO production. The levels of nitrite were determined by an assay kit according to the manufacturer's instructions. Briefly, a standard curve was prepared using a series of nitrite concentrations. One hundred microliters of samples were added in a 96-well microplate, and then the Griess reagentⅠand Ⅰ were sequentially added and mixed.
Next, the mixture was incubated at 37°C for 60 minutes. Finally, the OD values were determined at 550 nm with a spectrophotometer (Bio-Rad Laboratories).
Total RNA extraction and RT-PCR analysis for IKKα/β mRNA
Total RNA was extracted using a TRIzol (Invitrogen, USA) following the manufacturer's instructions. All reagents for complementary DNA (cDNA) synthesis and amplification were obtained from Invitrogen Co. (USA). Two micrograms of total RNA were used for cDNA synthesis. PCR was performed using Taq for 30 seconds and 72°C for 1 minute; and final extension of 72 °C for 5 minutes. Ten microliters of amplified products were separated on 1.5% agarose gels in
Tris-acetate-EDTA buffer (40 mmol/l Tris-acetate, 2 mmol/l Na 2 EDTA, pH 8.5) and then visualized under UV light. Finally, the assay of signal intensity was performed by image system (Bio-Rad).
Extraction of cytoplasmic and nuclear protein and immunoblotting analysis
The whole extraction procedure was performed following the method previously reported by Luo et al. with a minor modification (Luo et al. 2014 ). In the following procedure, all samples, reagents and tubes were pre-chilled and kept on ice. All centrifugations were performed at 12,000 rpm and 4°C. Briefly, HUVECs were collected and pelleted by centrifugation for 30 seconds in a 1.5 ml micro-centrifuge tube. The supernatants were removed and the cell pellets were re-suspended and washed in 1 ml of ice-cold Dulbecco's modified phosphate buffered saline (DPBS).
After another centrifugation, the pellets were re-suspended in a volume of hypo-osmotic lysis buffer (0.3 M sucrose, 2% (v/v) Tween 40, 10 mM HEPES-KOH pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM DTT, 0. was considered statistically significant.
Results

Effects of PIO on cell viability, caspase3 activity and cell function in HUVECs
In this study, we evaluated the cell injury degree, apoptosis and function by detecting the cell viability, caspase3 activity and the levels of NO and ET1, respectively. As shown in Fig.1 , Compared with the control group, exposure of HUVECs to HG for 48 hours notably decreased the cell viability and the levels of NO, while significantly elevated the caspase3 activity and the levels of ET1. In the contrary, treatment of PIO for 24 hours significantly antagonized the decreases in the cell viability and the NO levels and the elevations in the caspase3 activity and ET1 levels induced by HG, indicating PIO protects the cells against the injury, apoptosis and dysfunction induced by HG. Moreover, the protective effects manifest a certain degree of dose-dependent manner.
PIO attenuated the elevations of the IKKα/β expression levels induced by HG
Since IKKα/β-NFκB signaling is a typical inflammation pathway and diabetic vascular complication such as atherosclerosis is also a chronic inflammation process, we next sought to investigate whether treatment with PIO affects the IKKα/β expression. As anticipated, exposure of HUVECs to HG for 48 hours up-regulated considerably the levels of IKKα/β mRNA and its protein. However, treatment with PIO for 24 hours markedly attenuated the elevations of the IKKα/β expression levels D r a f t induced by HG in a dose dependent manner (Fig.2) .
PIO inhibited nuclear translocation of NFκB p65 induced by HG
Nuclear translocation of NFκB p65 from cytoplasm to nucleus, an important subunit of NFκB, plays a critical role in the secretion of inflammatory cytokines including IL-6 and TNFα etc.. Therefore, we subsequently evaluated the effect of treatment with PIO on the nuclear translocation of NFκB p65 under the condition of HG. As shown in Fig.3 , exposure of HUVECs to HG considerably induced the nuclear translocation of NFκB p65, manifesting a decrease in the cytoplasmic NFκB p65 levels while an increase in the nuclear NFκB p65 levels. Conversely, treatment with PIO for 24 hours markedly inhibited the nuclear translocation of NFκB p65
induced by HG in a dose-dependent manner.
PIO alleviated the elevations of inflammatory cytokines induced by HG
Inflammatory cytokines including IL-6 and TNFα etc. are the terminal factors of IKKα/β-NFκB signaling, which play predominant roles in inflammation. Hence, we ultimately observed the changes in these cytokines. As expected, exposure of HUVECs to HG considerably elevated the levels of IL-6 and TNFα. Instead, treatment with PIO for 24 hours markedly alleviated the elevations of inflammatory cytokines induced by HG in a dose-dependent manner (Fig.4) .
Inhibitory effects of PIO on inflammatory cytokines are mediated by PPARγ
Finally, we wondered whether the inhibitory effects of PIO on inflammatory cytokines are mediated by PPARγ. Two approaches were used to address this Finally, we wondered whether the inhibitory effects of PIO on NFκB signaling were through a mediation by PPARγ. To address this issue, two approaches were used.
One is to employ an antagonist of PPARγ and the other is to utilize the RNAi technique to specifically silence pparγ gene.. As expected, pretreatment of GW9662, an antagonist of PPARγ, abrogated the protective effects of PIO on the cell dysfunction and reversed the inhibitory effects of PIO on NFκB signaling. Moreover.
the down-regulation of PPARγ also achieved similar results. All these findings indicate that the protective effects of PIO on the cell dysfunction and the inhibitory effects on NFκB signaling are mediated by PPARγ.
Of course, the protective effects of PPARγ agonists on endothelial cell injury were identified by numerous other reports. It was shown that rosiglitazone, a PPARγ ligand, counteracts vascular dysfunction correlated with increased release of proinflammatory D r a f t substance elicited by micro-particles, a kind of plasma membrane vesicles containing pro-coagulant and pro-inflammatory properties. In addition, the underlying mechanisms were accounted for that activation of PPARγ by rosiglitazone attenuated the micro-particle-mediated increases in both interleukin IL6 and IL8 through the up-regulation and activation of NFκB (Ren et al. 2011) . It is noteworthy that oxidative stress is tightly relevant with inflammation, and ROS triggers inflammatory response mainly through IKK-NFκB signaling pathways. Thus, as the major target of inflammation, the pro-inflammatory transcription factor NFκB plays a pivotal role in the process of inflammatory responses (Harmon et al. 2011 ). The present study is only an investigation in vitro, and more researches in vivo need to be further performed.
Conclusions
In sum, the present study observed that PIO has a capability to protect HUVECs against the HG-induced injury and dysfunction in a dose-dependent manner and further confirmed that the underlying mechanism is a non-canonical PPARγ-mediated IKKα/β-NFκB inhibitory pathway. These findings highlight an insight into the possible intracellular signaling regarding hyperglycemia-induced endothelial cell injury and dysfunction and provide a novel potential for PIO to prevent and treat the vascular complications resulted from T2DM. 
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The treatment procedure of HUVECs was performed as described in Fig.1 .
Eventually, the cells were collected to measure the IKKα/β mRNA levels by RT-PCR (A) and its protein levels by immunoblotting analysis(B). All data were expressed as the means ± S.E.M of 3 independent experiments. **P < 0.01, vs. Control; # P < 0.05, ##P < 0.01, vs. HG.
Fig.3 PIO inhibited nuclear translocation of NFκB p65 induced by HG
The treatment procedure of HUVECs was performed as described in Fig.1 . The cytoplasmic proteins and nuclear proteins in HUVECs were extracted respectively to detect cytoplasmic (A) and nuclear (B) NFκB p65 levels with a monoclonal antibody D r a f t against p65 by immunoblotting analysis. β-actin and TBP were regarded as the cytoplasmic and nuclear internal control proteins, respectively. All data were expressed as the means ± S.E.M of 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, vs. Control; # P < 0.05, ##P < 0.01, ###P < 0.01, vs. HG.
Fig.4 PIO alleviated the elevations of inflammatory cytokines induced by HG
The treatment procedure of HUVECs was performed as described in Fig.1 . The cell supernatants were collected to detect the levels of IL6 (A) and TNFα (B). All data were expressed as the means ± S.E.M of 3 independent experiments. **P < 0.01, vs.
Control; # P < 0.05, ##P < 0.01, vs. HG.
Fig.5 Inhibitory effects of PIO on inflammatory cytokines are mediated by
PPARγ
The 95% confluent WT-HUVECs were first exposed to HG for 48 hours, and then pretreated with 10 µM of GW9662 for 30 minutes, and finally treated with 20 µM of PIO for another 24 hours. Meanwhile, the whole treated procedure of the PPARγ Low -HUVECs was the same as that of the WT-HUVECs. The levels of TNFα (A) and IL6 (B) were detected. All data were expressed as the means ± S.E.M of 3 independent experiments. *P < 0.05, **P < 0.01, vs. Control; # P < 0.05, ##P < 0.01, vs. HG; & P < 0.05, && P < 0.01, vs. HG+PIO20; $$ P < 0.01, vs. HG+PIO20 in WT-HUVECs. 160x80mm (300 x 300 DPI)
